Ribomic Revenue

In the fiscal year ending March 31, 2025, Ribomic had annual revenue of 2.00M JPY. Ribomic had revenue of -107.00K in the quarter ending March 31, 2025.

Revenue

2.00M

Revenue Growth

n/a

P/S Ratio

2,586.23

Revenue / Employee

80.00K

Employees

Market Cap

5.17B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	2.00M	-	-
Mar 31, 2024	-	-	-
Mar 31, 2023	65.00M	-15.00M	-18.75%
Mar 31, 2022	80.00M	-11.00M	-12.09%
Mar 31, 2021	91.00M	-30.00M	-24.79%
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,222.12B
Takeda Pharmaceutical Company	4,581.55B
HOYA Corporation	866.03B
Daiichi Sankyo Company	1,886.26B
Terumo	1,036.17B
Otsuka Holdings	2,393.18B
Astellas Pharma	1,912.32B
Shionogi &	438.27B

Revenue Rankings